R Squared’s MacroGenics MGNX Stock Holding History

R Squared’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,117	Closed	-$43.7K	–	632
2026 Q1	$43.7K	Sell	15,117 -774	-5%	-$1.65K	0.02%	425
2025 Q4	$25.6K	Buy	+15,891	New	+$25K	0.01%	485
2025 Q1	–	Sell	-570	Closed	-$1.85K	–	997
2024 Q4	$1.85K	Buy	+570	New	+$2.05K	﹤0.01%	1468

Other funds holding MGNX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

R Squared's MGNX Position: Q2 2026 in Review

R Squared sold out of MacroGenics (MGNX) in Q2 2026, closing a stake of 15,117 shares — an estimated $43.7K sold.

R Squared first reported a position in MGNX in Q4 2024 and held it in 3 quarters. The position peaked at $43.7K in Q1 2026. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

R Squared reported no remaining MacroGenics position as of Q2 2026 after selling out during the quarter.
R Squared sold 15,117 MacroGenics shares in Q2 2026, an estimated $43.7K.
R Squared first reported a position in MacroGenics in Q4 2024 and held it in 3 quarters.
R Squared's MacroGenics position peaked at $43.7K in Q1 2026.
122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.